|
Report Date : |
26.12.2013 |
IDENTIFICATION DETAILS
|
Name : |
TZ.M.L MEDICAL INDUSTRIES LTD. |
|
|
|
|
Formerly Known As : |
TZ.M.L MEDICAL SUPPLIES INDUSTRIES LTD |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
13.09.1984 |
|
|
|
|
Com. Reg. No.: |
No. 51-103937-2 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Importers and marketers of added-value medical disposables |
|
|
|
|
No. of Employees : |
Having 3 employees in subject, and 70 employees in
TZAMAL Group |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30th, 2013
|
Country Name |
Previous Rating (30.06.2013) |
Current Rating (30.09.2013) |
|
Israel |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
israEl ECONOMIC OVERVIEW
Israel has a technologically
advanced market economy. Its major imports include crude oil, grains, raw
materials, and military equipment. Cut diamonds, high-technology equipment, and
pharmaceuticals are among the leading exports. Israel usually posts sizable
trade deficits, which are covered by tourism and other service exports, as well
as significant foreign investment inflows. The global financial crisis of
2008-09 spurred a brief recession in Israel, but the country entered the crisis
with solid fundamentals - following years of prudent fiscal policy and a
resilient banking sector. The economy has recovered better than most advanced,
comparably sized economies. In 2010, Israel formally acceded to the OECD.
Israel's economy also has weathered the Arab Spring because strong trade ties
outside the Middle East have insulated the economy from spillover effects.
Natural gasfields discovered off Israel's coast during the past two years have
brightened Israel''s energy security outlook. The Leviathan field was one of
the world''s largest offshore natural gas finds this past decade, and
production from the Tama field is expected to meet all of Israel''s natural gas
demand beginning mid-2013. In mid-2011, public protests arose around income
inequality and rising housing and commodity prices. The government formed
committees to address some of the grievances but has maintained that it will
not engage in deficit spending to satisfy populist demands.
|
Source : CIA |
TZ.M.L MEDICAL INDUSTRIES LTD.
(TZ.M.L. also translated and known as ZAMAL or
TZAMAL)
Telephone 972
73 715 11 11
Fax 972
3 760 27 79
P.O. Box 7004 (4917001)
20 Hamagshimin Street
Kiryat Matalon Industrial Zone
PETACH TIKVA 4934829 ISRAEL
A private limited company,
incorporated as per file No. 51-103937-2 on the 13.09.1984.
Originally registered under
the name A.K.22 LTD., which changed to TZ.M.L MEDICAL SUPPLIES INDUSTRIES LTD.
on the 12.02.1985, which changed to the present name on the 16.04.2009.
Authorized share capital NIS 600.00, divided into: –
100,000 ordinary shares
of NIS 0.006 each,
of which 100 shares amounting to NIS 0.60 were issued.
Subject is fully owned
by TZ.M.L MEDICAL LTD., owned by Joshua (Shuki) Katz.
Yehushua (Shuki) Katz, Chairman of TZAMAL
MEDICAL Group.
Assaf Katz.
Importers and marketers of added-value medical disposables.
Sole local representatives
of:
·
CONMED,
RUHOF, both of USA,
IBSA, of Switzerland.
Sales are mainly to healthcare funds, medical institutes, clinics and
hospitals.
Amongst clients: HADASSA MEDICAL ORGANISATION, CLALIT HEALTH SERVICES
(Israel's largest Healthcare Fund), SAREL – LOGISTICS SOLUTIONS & PRODUCTS
FOR ADVANCED MEDICINE, SHEBA MEDICAL CENTER (TEL HASHOMER Hospital), ELIAS
SORASKY MEDICAL CENTER TEL AVIV (ICHILOV Hospital), RAMBAM MEDICAL CENTER,
ASSUTA Hospital, SHAAREY TZEDEK Hospital, etc..
Operating from rented premises (part of TZAMAL Group compound, which
includes offices and storage facilities), on an area of 600 sq. meters, in 20
Hamagshimim Street, Kiryat Matalon Industrial Zone, Petach Tikva.
Having 3 employees in
subject, and 70 employees in TZAMAL Group.
Current Stock is valued at NIS 1,000,000.
Other financial data not forthcoming.
There are 6 charges
for unlimited amounts registered on the company’s assets (all assets), in favor
of Bank
Leumi Le'Israel Ltd., Bank Hapoalim Ltd. and companies (last
2 charges placed October 2011, prior 2 charges placed in 1985, 1999 and in year
2000).
2012 sales claimed to be NIS 6,000,000.
Projected 2013 sales are NIS 6,000,000.
TZAMAL MEDICAL Group also includes (following are actually owned and
controlled by Shuki Katz), among others:
TZ.M.L. MEDICAL LTD., holding company, heads TZAMAL Group,
TZAMAL JAKOBSOHN LTD., 63.4% owned by subject, importers and marketers of
perishable and non-perishable medical devices and technology for surgery,
orthopedics & sports medicine, cardiovascular, neurosurgery & E.N.T,
spine.
TZAMAL BIO-PHARMA LTD., 74%, importers and marketers of medicines for
operation rooms.
TZAMAL 2B CAPITAL MEDICAL EQUIPMENT LTD., High-tech capital
equipment for all areas of the healthcare industry,
TZAMAL MEDICARE LTD., innovative technology for primary and home care,
INFOTECH LTD., developers and marketers of infusion pumps and supplementary
equipment,
TZAMAL INVESTMENTS LTD., investing in medical equipment start-ups.
M. P. VET LTD., 90%, importers and marketers of veterinary medicines. 2010
revenues US$ 1.5 million.
Bank Leumi Le'Israel Ltd., Kiryat Arie Business Branch (No. 670), Petach Tikva,
account no. 58800/65.
A check with the Central Banks' database did not reveal anything
detrimental on subject’s a/m account.
Nothing unfavorable learned.
TZAMAL MEDICAL Group
is a long established business, established in 1972, well-known in the local
market, with good reputation.
Subject ceased
manufacturing and closed its plant in Hadera.
Shuki Katz, was a
shareholder with Yehuda Gil in TZMAL MODERN EQUIPMENT LTD. which they
established in 1972, and which operated in a similar field as subject. The
company was split in 1999, Mr. Katz sold his shares in this company and some of
its activities were transferred to subject (the former company changed its name
to Y. GIL MEDICAL LTD.).
In August 2001, it
was reported that the TZAMAL Group signed a deal to represent PROCHON, a local
bio-technology company. The deal was valued at hundreds and thousands of US
Dollars.
Israel is
considered one of the leading countries in the world in terms of investment in
the Life Science and Biotechnology industry. In 2008 Israel was ranked 4th in investments in Biotechnology/GDP, while being among the leaders in the areas
of investments and patents in Medical Device and
Bio-Pharma fields.
During 2008 total
of US$ 87 million were given to local Life Science firms by the Chief Scientist
Office.
Local consumption
market for medical and aesthetic electronic equipment and instrumentation was
estimated at over US$ 1 billion (sales by local manufacturers and from import),
based on the Ministry of Industry & Trade research in 2009.
According to the
Ministry of Industry & Trade survey in 2008, there are some 160 local
companies operating in the medical equipment field.
Good for trade engagements.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.61.87 |
|
UK Pound |
1 |
Rs.101.10 |
|
Euro |
1 |
Rs.84.65 |
INFORMATION DETAILS
|
Report
Prepared by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.